What is the ticker symbol for Neurocrine Biosciences, Inc.?

The ticker symbol for Neurocrine Biosciences, Inc. is NASDAQ:NBIX

Does Neurocrine Biosciences, Inc. pay dividends?

No, Neurocrine Biosciences, Inc. does not pay dividends

What sector is Neurocrine Biosciences, Inc. in?

Neurocrine Biosciences, Inc. is in the Healthcare sector

What industry is Neurocrine Biosciences, Inc. in?

Neurocrine Biosciences, Inc. is in the Specialty & Generic Drug Manufacturers industry

What country is Neurocrine Biosciences, Inc. based in?

Neurocrine Biosciences, Inc. is headquartered in United States

When did Neurocrine Biosciences, Inc. go public?

Neurocrine Biosciences, Inc. initial public offering (IPO) was on May 23, 1996

Is Neurocrine Biosciences, Inc. in the S&P 500?

No, Neurocrine Biosciences, Inc. is not included in the S&P 500 index

Is Neurocrine Biosciences, Inc. in the NASDAQ 100?

No, Neurocrine Biosciences, Inc. is not included in the NASDAQ 100 index

Is Neurocrine Biosciences, Inc. in the Dow Jones?

No, Neurocrine Biosciences, Inc. is not included in the Dow Jones index

When was Neurocrine Biosciences, Inc. last earnings report?

Neurocrine Biosciences, Inc.'s most recent earnings report was on July 30, 2026

When does Neurocrine Biosciences, Inc. report earnings?

The next expected earnings date for Neurocrine Biosciences, Inc. is October 28, 2026

NBIX Stock Financials, Chart, Sentiment & Profile

Summary

Current Price: As of today, NBIX price is $155.64, down -1.71% on September 4, 2026
Current Price All-Time High: NBIX price is currently -16.38% below its historical high of $186.12 set on July 30, 2026
Market Cap: NBIX current market cap is $16B, up +13.82% over the past 365 days
PE Ratio: NBIX current PE ratio is 22.80
Revenue: NBIX current annual revenue is $2.86B, up +21.45% year-over-year
Next Earnings: The next earnings release for NBIX is on October 28, 2026

Profile

Company profile for Neurocrine Biosciences, Inc. (NBIX)
Metric	Value
Full Name	Neurocrine Biosciences, Inc.
Ticker	NASDAQ: NBIX
Exchange	NASDAQ
Sector	Healthcare
Industry	Specialty & Generic Drug Manufacturers
Country	United States
IPO	May 23, 1996
Indexes	Not included
Website	neurocrine.com
Employees	1,800

Key Metrics

Neurocrine Biosciences, Inc. Key Details
Metric	Value	Date
Price	$155.64	Sep 4, 26
Price, 1D Change	-1.71%	Sep 4, 26
Market Cap	$16B	Sep 4, 26
	-	Sep 4, 26
PE Ratio	22.80	Sep 4, 26
Beta	0.66	Sep 4, 26
Revenue	$2.86B	Dec 31, 25
Revenue, 1Y Change	+21.45%	Dec 31, 25
EPS	$4.67	Dec 31, 25
EPS, 1Y Change	+41.87%	Dec 31, 25

Events

Neurocrine Biosciences, Inc. Events
Metric	Value	Date
Next Earnings		Oct 28, 26
Last Qtr. Earnings		Jul 30, 26
Last Ann. Earnings		Feb 11, 26
Last Ex-Dividend	N/A	N/A
Next Ex-Dividend	N/A	N/A
Last Split	N/A	N/A
Next Split	N/A	N/A
Last Ticker Change	N/A	N/A
Next Ticker Change	N/A	N/A

🔒 Log In To Unlock Full Data

Estimates

NBIX Estimates
Metric	Value	Date
EPS	$4.67	Dec 31, 25
EPS Estimate	$10.20	N/A
EPS Est. Change	+118.38%	N/A
Revenue	$2.86B	Dec 31, 25
Revenue Estimate	$3.90B	N/A
Revenue Est. Change	+36.42%	N/A
Current Price	$155.64	Sep 4, 26
Price Target	$215.00	-
Price Tgt. Change	+38.14%	-

🔒 Log In To Unlock Full Data

EPS

NBIX EPS reported versus estimate values
Year	Estimate	Reported	Surprise / Exp.
2024	$6.58	$3.29	-49.95%
2025	$6.81	$4.67	-31.48%
2026	$10.20	N/A	+118.38%
2027	$11.97	N/A	+156.43%

Revenue

NBIX revenue reported versus estimate values chart
Year	Estimate	Reported	Surprise / Exp.
2024	$2.36B	$2.36B	-0.04%
2025	$2.84B	$2.86B	+0.58%
2026	$3.90B	N/A	+36.42%
2027	$4.55B	N/A	+59.19%

🔒 Log In To Unlock Full Data

Performance

NBIX Performance
Metric	Value	Date
Price, 1Y	+10.85%	Sep 4, 26
Price, 3Y	+40.69%	Sep 4, 26
Market Cap, 1Y	+13.82%	Sep 4, 26
Market Cap, 3Y	+46.52%	Sep 4, 26
Revenue, 1Y	+21.45%	Dec 31, 25
Revenue, 3Y	+92.15%	Dec 31, 25
EPS, 1Y	+41.87%	Dec 31, 25
EPS, 3Y	+198.89%	Dec 31, 25

🔒 Log In To Unlock Full Data

Technicals

NBIX Technical Indicators
Metric	Value	Date
Current Price	$155.64	Sep 4, 26
SMA 200	$147.54	Sep 4, 26
SMA 50	$165.87	Sep 4, 26
EMA 200	$150.49	Sep 4, 26
EMA 50	$160.36	Sep 4, 26
MACD	-$2.38	Sep 4, 26
Beta	0.66	Sep 4, 26
ATR	$4.44	Sep 4, 26
14-Day RSI	44.05	Sep 4, 26
10-Day Volatility	18.59%	Sep 4, 26

Dividends

NBIX Dividends
Metric	Value	Date
	-	N/A
Upcoming	N/A	N/A
	-	Sep 4, 26
	-	Dec 31, 25
	$0.00	Dec 31, 25
	0.00%	Dec 31, 25

🔒 Log In To Unlock Full Data

Income & Profitability

NBIX Income & Profitability
Metric	Value	Date
Revenue	$2.86B	Dec 31, 25
EPS	$4.67	Dec 31, 25
Gross Profit	$2.81B	Dec 31, 25
Gross Margin	98.18%	Dec 31, 25
Operating Income	$636.50M	Dec 31, 25
Operating Margin	22.25%	Dec 31, 25
Net Income	$478.60M	Dec 31, 25
Net Margin	16.73%	Dec 31, 25
EBITDA	$666.60M	Dec 31, 25

🔒 Log In To Unlock Full Data

Financial Health

NBIX Financial Health
Metric	Value	Date
Debt To Equity	0.14	Dec 31, 25
	3.39	Dec 31, 25
	3.30	Dec 31, 25
	-	Dec 31, 25
	6	Jun 30, 26
	7.95	Sep 4, 26

Valuations

NBIX Valuations
Metric	Value	Date
PE Ratio	22.80	Sep 4, 26
	4.69	Sep 4, 26
	4.28	Sep 4, 26
	18.55	Sep 4, 26
	-	N/A

Balance Sheet

NBIX Balance Sheet
Metric	Value	Date
Book Value	$3.25B	Dec 31, 25
	$1.48B	Dec 31, 25
	$4.75B	Dec 31, 25
	$2.52B	Dec 31, 25
	$1.50B	Dec 31, 25
	$743.40M	Dec 31, 25
Total Debt	$471.30M	Dec 31, 25
	$56.00M	Dec 31, 25
	$104.90M	Dec 31, 25

Expenses

NBIX Expenses
Metric	Value	Date
	$2.38B	Dec 31, 25
	$2.17B	Dec 31, 25
	$52.10M	Dec 31, 25
	$0.00	Dec 31, 25
	$30.10M	Dec 31, 25
	$0.00	Dec 31, 25
	$226.80M	Dec 31, 25

Cash Flow

NBIX Cash Flow
Metric	Value	Date
	$782.70M	Dec 31, 25
	-$264.40M	Dec 31, 25
	-$38.30M	Dec 31, 25
Capex	$34.00M	Dec 31, 25
	$748.70M	Dec 31, 25

Recent analyst updates

NBIX Recent analyst updates
Metric	Value	Date
Citigroup	→	Sep 3, 26
Morgan Stanley	→	Aug 13, 26
Wedbush	→	Aug 3, 26
Truist Securities	→	Aug 3, 26
Canaccord Genuity	→	Aug 3, 26
TD Cowen	→	Jul 31, 26
Stifel	→	Jul 31, 26
RBC Capital	→	Jul 31, 26
Piper Sandler	→	Jul 31, 26
Needham	→	Jul 31, 26

Analyst sentiment

Institutional ownership

Screeners with NBIX

FAQ

What is the ticker symbol for Neurocrine Biosciences, Inc.?: The ticker symbol for Neurocrine Biosciences, Inc. is NASDAQ:NBIX
Does Neurocrine Biosciences, Inc. pay dividends?: No, Neurocrine Biosciences, Inc. does not pay dividends
What sector is Neurocrine Biosciences, Inc. in?: Neurocrine Biosciences, Inc. is in the Healthcare sector
What industry is Neurocrine Biosciences, Inc. in?: Neurocrine Biosciences, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Neurocrine Biosciences, Inc. based in?: Neurocrine Biosciences, Inc. is headquartered in United States
When did Neurocrine Biosciences, Inc. go public?: Neurocrine Biosciences, Inc. initial public offering (IPO) was on May 23, 1996
Is Neurocrine Biosciences, Inc. in the S&P 500?: No, Neurocrine Biosciences, Inc. is not included in the S&P 500 index
Is Neurocrine Biosciences, Inc. in the NASDAQ 100?: No, Neurocrine Biosciences, Inc. is not included in the NASDAQ 100 index
Is Neurocrine Biosciences, Inc. in the Dow Jones?: No, Neurocrine Biosciences, Inc. is not included in the Dow Jones index
When was Neurocrine Biosciences, Inc. last earnings report?: Neurocrine Biosciences, Inc.'s most recent earnings report was on July 30, 2026
When does Neurocrine Biosciences, Inc. report earnings?: The next expected earnings date for Neurocrine Biosciences, Inc. is October 28, 2026

Data Sources & References

NBIX Official Website www.neurocrine.com
Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/914475/000091447526000007/0000914475-26-000007-index.htm
NBIX Profile on Yahoo Finance finance.yahoo.com/quote/NBIX
NBIX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nbix